title: Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate.
authors.forename: B
authors.initials: B
authors.lastname: Arora
authors.forename: L
authors.initials: L
authors.lastname: Kumar
authors.forename: A
authors.initials: A
authors.lastname: Sharma
authors.forename: J
authors.initials: J
authors.lastname: Wadhwa
authors.forename: V
authors.initials: V
authors.lastname: Kochupillai
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001549:Benzamides; D005076:Exanthema / Q000139:chemically induced; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D010859:Pigmentation Disorders / Q000139:chemically induced* / Q000503:physiopathology; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use*; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate